Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Single Dose, Open-Label, Exploratory Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

NCT02872701 is registered in ClinicalTrials.gov with On Target Laboratories, LLC as lead sponsor.

NCT NCT02872701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02872701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Single Dose, Open-Label, Exploratory Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
Lead sponsor
On Target Laboratories, LLC
Phase
Phase 2
Overall status
Completed
Start date
May 4, 2017
Completion date
November 30, 2018
Enrollment
100 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung neoplasms